ELISA in mAb Pharmacokinetics Research

1. The Importance of ELISA in mAb PK Research

The enzyme-linked immunosorbent assay (ELISA) analytical method achieves sensitive detections while maintaining easy use which makes it broadly adopted in pharmacokinetic (PK) research. ELISA produces essential ADME information for macromolecular medicines such as monoclonal antibodies and peptide drugs. The results of these studies provide essential information to create dosing schedules that optimize therapeutic advantages and reduce toxic side effects. In monoclonal antibody PK research scientists use ELISA to detect anti-drug antibody formation which reveals how ADA immunogenicity impacts the drug's effectiveness and safety. Personalized treatment plan design requires this data especially when notable individual variability in mAb PK shows up.

3. ELISA Procedure and Considerations

ELISA may look simple but requires multiple exact procedures that guarantee accurate and sensitive results.

• Preparation of Blank Wells and Standard Samples
  Scientists leave blank wells empty to avoid interference from external substances. A range of standard solutions at different concentrations is prepared and placed in specific wells to create an accurate concentration range while quality control wells (QC1 and QC2) receive QC solutions to maintain experimental consistency.
• Addition of Samples and Reagents
  The diluted samples enter the sample wells while primary antibody solutions are introduced into each well without sample blanks for full antigen binding. This step needs to be done at room temperature because it supports a comprehensive reaction.
• Washing and Incubation
  Each well is washed with a buffer using an ELISA washer to remove unbound reagents and impurities, thereby preventing cross-reactivity. Following washing, a biotinylated antibody is added and incubated at room temperature to ensure specific binding.
• Signal Enhancement and Colorimetric Reaction
  An HRP-labeled antibody is added to each well, and after incubation, TMB substrate is introduced. The reaction between TMB and HRP produces a blue signal, which is then measured with a spectrophotometer to ensure detection sensitivity and accuracy.
• Reaction Termination and Data Reading
  An acidic solution is added to stop the reaction, changing the color from blue to yellow. The absorbance is then read at 450 nm, and the drug concentration is calculated by comparing the optical density (OD) values against the standard curve.
• Standard Curve and Sample Concentration Calculation
  A standard curve is plotted using the known concentrations of the standard solutions and their corresponding OD values. The concentration of the drug in each sample is determined by comparing its OD value to the curve.

Figure 3. Evaluation of Ustekinumab Trough Concentrations Using Two ELISA Kits in Crohn's Disease (Source: Kwon Y, et al. 2022)

With ongoing technological advances, the application of ELISA in PK research will continue to be refined, and its role in ADA immunogenicity studies will become even more pivotal. Creative Diagnostics offers a range of high-quality ELISA kits for various mAb PK analyses. You can click on the "Reagent Solutions" link at the top of our page to view our highly rated products or search for a specific mAb on our homepage to filter ELISA kits. Not sure which one to choose? Contact our team for professional recommendations.

ADA ELISA Kits

PK ELISA Kits